EWTX
NASDAQ · Pharmaceuticals
Edgewise Therapeutics Inc
$43.52
-0.90 (-2.03%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+43.87%
1Y
+236.06%
YTD
+83.24%
Open$44.00
Previous Close$44.42
Day High$44.20
Day Low$42.46
52W High$48.40
52W Low$12.30
Volume—
Avg Volume808.3K
Market Cap4.42B
P/E Ratio—
EPS$-1.66
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$26.49
Above
SMA 200
$18.41
Above
RSI (14)
53.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
+61.9% upside
Current
$43.52
$43.52
Target
$70.44
$70.44
$45.77
$70.44 avg
$86.30
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 407.17M | 429.50M | 324.39M |
| Net Income | 72.15M | 91.13M | 54.38M |
| Profit Margin | 17.7% | 21.2% | 16.8% |
| EBITDA | 147.48M | 172.82M | 113.17M |
| Free Cash Flow | 69.60M | 65.40M | 42.96M |
| Rev Growth | +16.1% | +0.2% | +22.1% |
| Debt/Equity | 0.29 | 0.25 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.1 | 32.02B |